INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 129 filers reported holding INTERSECT ENT INC in Q2 2017. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $359,000 | +68.5% | 21,023 | +61.1% | 0.04% | +5.9% |
| Q3 2020 | $213,000 | +33.1% | 13,050 | -3.4% | 0.03% | +9.7% |
| Q1 2020 | $160,000 | -63.0% | 13,508 | -2.5% | 0.03% | -55.7% |
| Q3 2017 | $432,000 | +45.5% | 13,853 | +30.2% | 0.07% | +25.0% |
| Q2 2017 | $297,000 | +65.9% | 10,641 | -22.8% | 0.06% | +16.7% |
| Q2 2016 | $179,000 | – | 13,783 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |